History Of Cadiology

Home » Neurology

« Go Back

Accelitech’s 7th CyberKnife to Open in Miami

Mercy Hospital and Accelitech have partnered to bring the CyberKnife Stereotactic Radiosurgery System to Miami

Ziosoft Announces Appointment of Joan Main, Director of Luminary Development

Main joined Ziosoft (http://www.ziosoftinc.com/) effective December 31, 2009.

Biocoat Installs New Automated Coating Equipment to Increase Coatings Capacity

New automated dip coating apparatus that allows increased coatings development capacity.

National Silver Alert® Introduces Personal GPS Tracker

Providing peace of mind to the caregivers of those with Alzheimer’s, cognitive disorders, special needs and health problems.

The US Drug Watchdog's Warns All Americans About Gadolinium-Medical MRI's- Kidney Disease & NSF

The US Drug Watchdog is warning all US citizens about a dye used in MRI's called Gadolinium, particularly for individuals who have kidney disease who were exposed to this dye, and who may now have an incurable medical condition called NSF. According to the group, "we think there could be literally thousands of US citizens who have had a MRI, where a dye called Gadolinium was used, that caused a horrible condition called NSF, and no one has ever heard of NSF. We fear that individuals with kidney disease, who have had a MRI in the last 10 years, where Gadolinium was used, may now have NSF, without ever knowing it." The symptoms of NSF include: Patients with NSF describe swelling and tightening of the skin. The skin thickening inhibits flexibility and extension of joints, resulting in contractures. Severely affected patients may be unable to walk, or fully extend the joints of their arms, hands, legs, and feet. Complaints of muscle weakness are common. If a person has had a MRI, where Gadolinium may have been used, and they have developed these symptoms, they should contact the US Drug Watchdog immediately at 866-714-6466, or contact the group via its web site at Http://USDrugWatchdog.Com

PET Scans May Help Diagnose Movement Disorders

Can brain scans help diagnosis Parkinson’s disease at the onset of symptoms? One clever way to know for sure is to take snapshots of the brain at the time of the first symptoms of tremor or rigidity, and follow the patients over the years to see whether the diagnosis was correct. About 10 to 20 percent of patients initially thought to have Parkinson’s suffer from another movement disorder.

News from the Latest Issue of Molecular Medicine

New research from the bimonthly biomedical journal, Molecular Medicine. Molecular Medicine publishes research concerned with the pathogenesis of disease at the molecular level, in order to design specific molecular tools for disease diagnosis, treatment and prevention.

First Global, Virtual Summit on Cognitive Health and Performance Features 200 Sharp Brains

Leading neuroscientists, health professionals, technologists, and innovators in 15 countries participate in SharpBrains Summit without taking a single flight

Genetix Pharmaceuticals’ Adrenoleukodystrophy (ALD) Product Recognized As One of Science Magazine’s Top 10 Scientific Breakthroughs of 2009

ALD Patients Featured in Science Article Now Living Healthy and Normal Lives Due to Groundbreaking Gene Therapy

CME Outfitters Announces neuroscienceCME Journal Club Series: "Management of Multiple Sclerosis"

Offered as a series of two live webcasts/audioconferences premiering Monday, January 25, 2010, from 12:00 p.m.-1:00 p.m. ET, the continuing education series will translate consensus recommendations on differential diagnosis into effective management of patients with MS, and increase awareness surrounding the potential risk factor of white matter pathology for the development of MS. Clinicians can earn up to 2.0 CE credits by completing both parts; participation is available online or by phone.

Pages: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 Next

Page 9 of 45